Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
- 1 June 1997
- journal article
- Published by Elsevier in The Lancet
- Vol. 349 (9069), 1857-1863
- https://doi.org/10.1016/s0140-6736(96)11445-8
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.Journal of Clinical Investigation, 1996
- Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: A controlled double-blind trialAmerican Journal of Kidney Diseases, 1996
- Abnormal protein traffic through the glomerular barrier induces proximal tubular cell dysfunction and causes renal injuryCurrent Opinion in Nephrology and Hypertension, 1995
- Long-term comparison between captopril and nifedipine in the progression of renal insufficiencyKidney International, 1992
- Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.Journal of Clinical Investigation, 1990
- Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathyKidney International, 1986
- EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHYThe Lancet, 1983
- Long-term antihypertensive treatment inhibiting progression of diabetic nephropathyBMJ, 1982
- Dietary Protein Intake and the Progressive Nature of Kidney Disease:New England Journal of Medicine, 1982
- Repeated assessment of results in clinical trials of cancer treatmentThe British Journal of Radiology, 1971